1. Home
  2. GLAD vs RAPP Comparison

GLAD vs RAPP Comparison

Compare GLAD & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLAD
  • RAPP
  • Stock Information
  • Founded
  • GLAD 2001
  • RAPP 2022
  • Country
  • GLAD United States
  • RAPP United States
  • Employees
  • GLAD N/A
  • RAPP N/A
  • Industry
  • GLAD Finance/Investors Services
  • RAPP
  • Sector
  • GLAD Finance
  • RAPP
  • Exchange
  • GLAD Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • GLAD 547.5M
  • RAPP 463.8M
  • IPO Year
  • GLAD N/A
  • RAPP 2024
  • Fundamental
  • Price
  • GLAD $25.42
  • RAPP $10.62
  • Analyst Decision
  • GLAD Hold
  • RAPP Strong Buy
  • Analyst Count
  • GLAD 1
  • RAPP 5
  • Target Price
  • GLAD $23.00
  • RAPP $35.00
  • AVG Volume (30 Days)
  • GLAD 144.4K
  • RAPP 171.1K
  • Earning Date
  • GLAD 05-06-2025
  • RAPP 05-10-2025
  • Dividend Yield
  • GLAD 9.36%
  • RAPP N/A
  • EPS Growth
  • GLAD 60.05
  • RAPP N/A
  • EPS
  • GLAD 4.63
  • RAPP N/A
  • Revenue
  • GLAD $95,360,000.00
  • RAPP N/A
  • Revenue This Year
  • GLAD N/A
  • RAPP N/A
  • Revenue Next Year
  • GLAD $10.81
  • RAPP N/A
  • P/E Ratio
  • GLAD $5.49
  • RAPP N/A
  • Revenue Growth
  • GLAD 5.53
  • RAPP N/A
  • 52 Week Low
  • GLAD $20.85
  • RAPP $6.43
  • 52 Week High
  • GLAD $30.43
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • GLAD 48.73
  • RAPP N/A
  • Support Level
  • GLAD $23.85
  • RAPP N/A
  • Resistance Level
  • GLAD $25.20
  • RAPP N/A
  • Average True Range (ATR)
  • GLAD 1.07
  • RAPP 0.00
  • MACD
  • GLAD 0.18
  • RAPP 0.00
  • Stochastic Oscillator
  • GLAD 98.58
  • RAPP 0.00

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: